- Editor's PickYahoo Finance•yesterday
Toll Brothers (TOL) shares are higher after the company posted earnings and revenue that beat Wall Street’s expectations. Toll, whose homes can cost more than $2 million, said orders rose about 22% in the quarter ended Jan. 31. Bristol-Myers Squibb (BMY) shares are in focus after a report that billionaire investor Carl Icahn has taken a stake in the drugmaker.
- Insider Monkey•2 hours ago
Bristol-Myers Squibb Co (NYSE:BMY) will sell senior notes that are unsecured worth $1.5 billion. Half of that amount is due in two years at a rate of 1.6% while the other half is due in a decade at a rate of 3.25%. The offering will be jointly managed by various investment banks and firms including […]
- Investor's Business Daily•3 hours ago
Merck and Roche are swiping share from Bristol-Myers Squibb's I-O drugs after their FDA approvals in advanced lung cancer.
BMY : Summary for Bristol-Myers Squibb Company Co - Yahoo Finance
Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||55.02 - 56.09|
|52 Week Range||46.01 - 77.12|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.04|
|Dividend & Yield||1.56 (2.85%)|
|1y Target Est||N/A|